Dr. Reddy's Laboratories
Search results
Divis is one of the Best Pharmaceutical Companies Hyderabad, India & World in manufacturing high quality of API Generic products with the highest level of compliance and integrity.
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. [ 5][ 6][ 2][ 7] The company manufactures and custom synthesizes generic APIs, intermediates. [ 8][ 9] The company also manufactures and supplies nutraceutical ...
Divis Labs Share Price: Find the latest news on Divis Labs Stock Price. Get all the information on Divis Labs with historic price charts for NSE / BSE.
Divi’s complies with cGMP guidelines for both the manufacturing units, having been inspected numerous times by FDA, EU GMP , HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities. One of the Largest Pharmaceutical Companies in the World.
91 (8922) 248922. Contact Best Pharmaceutical Companies in the World for Generic APIs Products - Call at +1 (973) 993 1060, +1 (973) 993 1070.
Get the latest Divi's Laboratories Ltd (DIVISLAB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
Divi’s Laboratories Limited is one of the largest API companies in the world, with ~$1.2B in revenue and exporting to more than 100 countries. Established in 1990, we are engaged in the...
3 days ago · Divi's Laboratories Limited Share Price Today, Live NSE Stock Price: Get the latest Divi's Laboratories Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account ...
Divi's Laboratories Ltd. ₹ 4,834 -2.26%. 08 Aug 4:04 p.m. Export to Excel. Follow. divislaboratories.com BSE: 532488 NSE: DIVISLAB. Read More. Market Cap ₹ 1,28,346 Cr. Current Price ₹ 4,834.
May 23, 2022 · One of India’s leading pharmaceutical companies, Divis Laboratories Ltd, announced its Q4FY22 result on May 23, 2022. Divis Laboratoriesposted a total income of Rs. 2,570.8 crores, up an impressive 41.8% Y-o-Y (year-on-year) from Rs. 1,811.7 crores in the year ago period.
